Common Stock, $0.01 par value
- Symbol
- PLXS
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 9.01 · 8-K
PLXSNASDAQEQUITYCurrent
Item 2.02 Results of Operations and Financial Condition. On July 29, 2026, Plexus Corp. (“we” or the “Company”) announced results for the fiscal third quarter ended July 4, 2026. A copy of the Company’s related press release is furnished as Exhibit 99.1 to this report.
Press release in this filing
Plexus Announces Fiscal Third Quarter Financial Results →At Plexus, we help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 27 facilities. For more information about Plexus, visit our website at www.plexus.com.
PLEXUS CORP. · 8-K · Filed 2026-07-29
EX-99.1 2 plxsf26q3er-ex991.htm EX-99.1 Document Plexus Announces Fiscal Third Quarter Financial Results NEENAH, WI - July 29, 2026 - Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal third quarter ended July 4, 2026, and guidance for our fiscal fourth quarter ending October 3, 2026. • Reports record fiscal third quarter 2026 revenue of $1.305 billion, GAAP operating margin of 4.7% and GAAP diluted EPS of $1.58. • Reports fiscal third quarter 2026 non-GAAP operating margin of 6.3% and non-GAAP diluted EPS of $2.32, excluding $0.74 of stock-based compensation expense. • Initiates fiscal fourth quarter 2026 revenue guidance of $1.330 billion to $1.380 billion with GAAP diluted EPS of $2.18 to $2.34, including $0.29 of stock-based compensation expense. Fiscal fourth quarter non-GAAP EPS guidance of $2.47 to $2.63 excludes stock-based compensation expense. Three Months Ended …
Open exhibit ↗